Companies › CYTK
CYTOKINETICS INC (CYTK)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001061983 · EDGAR filings · Updated 2026-07-27
CYTOKINETICS INC (CYTK) has reported institutional ownership of 117.4%, with 438 institutional managers holding positions valued at $9.62B per the latest 13F reporting period.
Filings this week (2)
- 2026-07-27 — Insider transaction reported (Form 4)
- 2026-07-23 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-16 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CYTOKINETICS INC has 438 institutional holders and institutional ownership of 117.4%.
Insider activity
Insiders reported 171 transactions (0 buys, 76 sells) across 15 reporting insiders, with a net reported value of −$25.1M.
Related companies
BEONE MEDICINES LTD (ONC) · REVVITY INC (RVTY) · SANOFI SA (SNY) · DAVITA INC (DVA) · MASIMO CORP (MASI) · VAXCYTE INC (PCVX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.